查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994376

導流板市場：2026-2032年全球市場預測（依產品類型、材質、塗層、應用、銷售管道和最終用戶分類）

Flow Diverters Market by Product Type, Material, Coating, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，分流器市場價值將達到 3.1004 億美元，到 2026 年將成長至 3.3076 億美元，到 2032 年將達到 4.6677 億美元，年複合成長率為 6.01%。

主要市場統計數據
基準年 2025 310,040,000 美元
預計年份：2026年 3.3076億美元
預測年份 2032 4.6677億美元
複合年成長率 (%) 6.01%

全面介紹血流導向裝置技術及其臨床應用趨勢，這些趨勢正在改變現代血管內治療中動脈瘤的治療方式。

血流導向裝置的出現，為複雜動脈瘤的治療方法帶來了突破性的血管內治療，將治療模式從傳統的彈簧圈栓塞轉變為基於支架的血管重組。這些裝置的主要功能是將血流從動脈瘤囊內分流，同時為內皮化提供支架，最終促進動脈瘤閉塞和血管癒合。過去十年間，從網孔密度和孔徑的改進到更精密的輸送系統，血流導向裝置的迭代創新不斷拓展了其技術可行性和臨床應用範圍。

對推動整個血流導向裝置生態系統創新和推廣的技術、監管和臨床變革進行詳細分析。

血流移位領域正經歷一系列變革，這些變革是由技術、監管和臨床因素的相互作用共同驅動的。從技術角度來看，研發人員正在改進結構設計，例如層級構造和單層編織結構，同時，Pipeline Flex 和 Silk 等產品的改良版本也在提升輸送性能和生物相容性。材料科學的創新，包括鎳鈦諾、鈷鉻合金和鉑合金的最佳化應​​用，以及先進表面處理技術的出現，正在提高造影和生物相容性。同時，從親水性塗層到聚合物層等各種新型塗層正被用於減少導航過程中的摩擦並控制植入後血栓的形成。

分析 2025 年美國關稅措施如何重塑整個流動轉移價值鏈的供應鏈韌性、採購行為和商業策略。

美國2025年實施的關稅政策對血流導向裝置的整個價值鏈產生了重大影響，涵蓋了從原料採購到醫療設備分銷的各個環節。對於依賴鈷鉻合金、鎳鈦合金和造影金等特殊的製造商而言，進口關稅的變化增加了投入成本，並促使他們重新審視供應商合約。為此，一些醫療設備製造商正在探索近岸外包策略和替代採購安排，以減輕關稅環境波動的影響，並在維持品管標準的同時保護其利潤率結構。

高解析度分割提供了將產品架構、臨床適應症、材料科學、塗層策略和通路與採用促進因素和設計重點聯繫起來的見解。

按產品類型、應用、最終用戶、材料、塗層和分銷管道對市場進行細分，可以清楚揭示產品性能特徵和關鍵因素，指南產品開發和商業化策略。在產品架構方面，層級構造和單層編織結構與 Pipeline Flex 和 Silk 等品牌平台並存。編織密度、徑向力和輸送系統幾何形狀的設計差異會影響臨床醫師針對特定形態和解剖挑戰的選擇。材料成分進一步最佳化了這些選擇。鎳鈦合金具有超彈性，適用於彎曲的解剖結構；鈷鉻合金可增強特定血管直徑的徑向強度；鉑金則用於增強植入過程中的滲透性性。特別是，已分別對鈷鉻合金、鎳鈦合金和鉑金材質的層級構造和層級構造器械系列進行了評估，以平衡可見度、適應性和結構韌性。

區域分析詳細說明了全球主要地區的管理體制、臨床網路和製造地如何推動差異化的採用和商業化策略。

區域趨勢對美洲、歐洲、中東、非洲和亞太地區的監管時間表、臨床應用率和供應鏈結構均有顯著影響。在美洲，由於監管管道和已建立的臨床網路，改進型醫療器材往往能夠迅速推廣，而大規模學術醫療中心和區域醫院的採購結構則存在巨大差異。這種差異促使製造商採用靈活的商業模式，將與醫療採購集團的直接合作與對門診機構的定向支持相結合。

深入了解領先的醫療設備製造商如何將產品創新、夥伴關係和上市後證據策略結合，以加強其市場地位和臨床價值提案。

領先的醫療設備製造商和生態系統參與者正採取多種策略來保持競爭優勢並滿足不斷變化的臨床需求。許多公司優先考慮產品迭代改進。具體而言，他們致力於改進輸送系統以實現低輪廓入路，透過材料選擇滲透性，並改進表面以影響血栓形成，同時投資於臨床證據的積累，以支持更廣泛的適應症聲明並爭取與支付方的合作。與影像服務提供者和手術系統供應商建立策略合作夥伴關係也日益普遍，旨在將醫療設備部署與增強的術中可視化和導航功能相結合。

為製造商、經銷商和臨床領導者提供具體的策略建議，以加快產品推廣、增強供應韌性並改善循證報銷結果。

產業領導者應優先採取一系列行動，將洞察轉化為永續優勢。製造商必須繼續投資於能夠降低手術複雜性、提高手術視野、最大限度減少材料用量的器械設計，同時確保結構完整性。同時，增加對健全的臨床註冊研究和有針對性的隨機試驗的投入，將有助於加強與支付方的溝通，並推動更廣泛的臨床應用，尤其是在長期療效對價值評估至關重要的解剖學領域。

為了檢驗策略見解，我們採用透明、多方面的調查方法，結合了對臨床醫生的訪談、監管審查、設備註冊分析和供應鏈資訊。

本研究的綜合結果基於一種多方面方法，該方法結合了與關鍵相關人員的對話和嚴謹的二手資訊分析。主要資訊來源包括對介入神經放射學和血管專科臨床醫生、醫院和門診診所的採購經理以及參與器械策略的高級銷售主管的深度訪談。這些訪談旨在深入了解器材性能、臨床決策和採購趨勢等方面的細微觀點。

簡潔結論總結了技術、臨床和商業性因素如何交織，決定了血流導向裝置應用和永續價值創造的未來方向。

總之，未來血流導引裝置技術的發展特徵在於器械設計、材料科學和臨床證據的融合，這些進步共同拓展了複雜動脈瘤形態的治療可能性。同時，諸如價格趨勢、不斷變化的醫保報銷機制以及監管和臨床基礎設施的區域差異等外部因素，正在影響著創新成果如何以及在何處轉化為患者照護。能夠整合價值鏈韌性、實證實踐和個人化商業性策略的相關人員，將更有利於實現永續的臨床和商業性價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 導流板市場：依產品類型分類

  • 雙層
    • 鈷鉻合金
    • 鎳鈦諾
    • 鉑
  • 管道軟性
  • 絲綢
  • 單層
    • 鈷鉻合金
    • 鎳鈦諾
    • 鉑

第9章 導流板市場：依材料分類

  • 鈷鉻合金
  • 鎳鈦諾
  • 鉑

第10章 按塗層分類的導流板市場

  • 基材
  • 親水塗層
  • 聚合物塗層

第11章 導流板市場：依應用領域分類

  • 顱內動脈瘤
    • 紡錘形
    • 囊狀
    • 扁平頸區
  • 周邊動脈瘤
    • 紡錘形
    • 扁平頸區

第12章 導流板市場：依通路分類

  • 直銷
  • 醫院藥房
  • 線上銷售
  • 零售藥房

第13章 導流板市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第14章 導流板市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 導流板市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 導流板市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國分流器市場

第18章：中國分流器市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH
  • Asahi Intecc
  • BALT Extrusion SA
  • Cook Medical LLC
  • InspireMD, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-1A1A064C05F2

The Flow Diverters Market was valued at USD 310.04 million in 2025 and is projected to grow to USD 330.76 million in 2026, with a CAGR of 6.01%, reaching USD 466.77 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 310.04 million
Estimated Year [2026] USD 330.76 million
Forecast Year [2032] USD 466.77 million
CAGR (%) 6.01%

Comprehensive introduction to flow diverter technology and clinical adoption trends reshaping aneurysm management across modern endovascular practice

Flow diverters have emerged as a transformational endovascular option for the management of complex aneurysms, shifting treatment paradigms away from traditional coil embolization toward scaffold-based vessel reconstruction. At their core, these devices act by diverting hemodynamic flow away from the aneurysm sac while providing a scaffold for endothelialization, ultimately promoting aneurysm occlusion and vessel healing. Over the past decade, iterative device innovations-ranging from refinements in braid density and pore size to enhanced delivery systems-have broadened both the technical feasibility and the clinical indications for flow diversion.

Clinicians now consider flow diverters for lesions that were historically difficult to treat, such as wide-neck saccular aneurysms, fusiform morphologies, and certain peripheral aneurysms. Advances in imaging modalities and periprocedural management have reduced some procedural risks, enabling wider adoption across neurointerventional and vascular surgical practices. Concurrently, materials science has played a pivotal role: nitinol and cobalt chromium form the structural backbone of many modern constructs, while platinum and other radiopaque elements improve visualization during deployment.

As the therapeutic landscape evolves, stakeholders from clinical, manufacturing, and distribution domains are converging to address device-specific performance, patient selection algorithms, and real-world outcomes evaluation. This introduction frames the subsequent analysis by highlighting how device design, clinical practice, and system-level factors interrelate to shape the contemporary use and future trajectory of flow diverters.

Deep analysis of technological, regulatory, and clinical shifts that are collectively accelerating innovation and adoption across the flow diverter ecosystem

The landscape of flow diversion is undergoing a set of transformative shifts driven by concurrent technological, regulatory, and clinical forces. From a technology standpoint, developers are refining structural architectures such as dual-layer constructs and single-layer braids, while product iterations like Pipeline Flex and Silk variants push improvements in deliverability and conformability. Material science innovations, including optimized uses of nitinol, cobalt chromium, and platinum alloys, together with the advent of advanced surface treatments, are enhancing both radiopacity and biocompatibility. At the same time, novel coatings-ranging from hydrophilic finishes to polymeric layers-are deployed to reduce friction during navigation and to modulate thrombogenicity post-implantation.

Clinically, the evidence base has matured beyond early feasibility and pivotal studies to include larger registry datasets and longer-term outcome analyses, which collectively inform guidelines and operator preferences. These clinical data have catalyzed broader consideration of flow diversion for a wider array of aneurysm morphologies, including both saccular and fusiform types, and have prompted multidisciplinary care pathways that integrate neurointerventionalists, vascular surgeons, and critical care teams. Regulatory environments have also adapted; expedited pathways for devices demonstrating clear clinical benefit and iterative approvals for delivery-system enhancements are shortening time-to-adoption in some jurisdictions, while reimbursement structures are evolving to recognize the long-term cost offsets associated with durable aneurysm occlusion.

Operationally, the setting of care is shifting as well. Ambulatory surgical centers and specialty clinics are increasingly capable of supporting select endovascular cases, driven by advances in imaging and anesthesia protocols and a focus on value-based care. Distribution and procurement models are likewise being reconfigured: manufacturers balance direct sales approaches with partnerships to hospital pharmacies and third-party distributors, and digital channels are emerging as complementary routes to reach smaller clinical facilities. Collectively, these shifts are aligning to accelerate innovation cycles, alter competitive dynamics, and demand more sophisticated coordination across clinical, regulatory, and commercial functions.

Analysis of how United States tariff measures in 2025 reshaped supply chain resilience, procurement behavior, and commercial strategies across the flow diverter value chain

The imposition of tariffs in the United States during 2025 has exerted a noticeable influence across the flow diverter value chain, from raw material procurement to device distribution. For manufacturers reliant on specialized metals such as cobalt chromium, nitinol, and radiopaque platinum, changes in import duties have elevated input costs and prompted reassessments of supplier contracts. In response, several device producers are examining nearshoring strategies and alternative sourcing arrangements to mitigate exposure to volatile tariff environments and to preserve margin structures while maintaining quality control standards.

Distribution channels have felt the secondary effects of tariff-driven cost pressures. Hospital procurement teams and ambulatory surgical centers have intensified negotiations around unit pricing and service bundles, seeking predictable total cost of ownership while preserving access to advanced devices. This dynamic has placed increased emphasis on value demonstration in clinical outcomes and on post-market performance data to justify premium pricing or to negotiate favorable purchasing terms. Meanwhile, some manufacturers have adjusted their commercial models-balancing direct sales relationships with hospital pharmacies and retailers against online sales strategies that emphasize transparency and reach.

Regulatory and strategic responses have emerged alongside these commercial shifts. Firms are accelerating investment in manufacturing process efficiencies and design optimizations that reduce material intensity without compromising structural integrity. Clinical teams have highlighted the importance of robust real-world registries to validate device longevity and to support reimbursement discussions. In addition, the tariff environment has catalyzed collaborative conversations between industry and payers about reimbursement frameworks that reflect long-term clinical benefit rather than short-term cost minimization. Taken together, the cumulative impact of tariffs has been to amplify the importance of supply chain resilience, to incentivize design economies, and to sharpen the commercial focus on evidence-driven value propositions.

High-resolution segmentation insights linking product architecture, clinical indication, material science, coating strategies, and distribution pathways to adoption drivers and design priorities

Disaggregating the market by product type, application, end user, material, coating, and distribution channel reveals distinct performance attributes and adoption drivers that inform product development and commercialization strategies. When considering product architectures, dual-layer constructs and single-layer braids coexist with branded platforms such as Pipeline Flex and Silk variants; design differentials around braid density, radial force, and delivery system profile influence clinician preference for specific morphologies and anatomical challenges. Material composition further refines these choices, with nitinol delivering superelastic properties for tortuous anatomies, cobalt chromium providing enhanced radial strength for certain vessel diameters, and platinum employed selectively to enhance radiopacity during deployment. Notably, dual-layer and single-layer device families are each evaluated across cobalt chromium, nitinol, and platinum configurations to balance visibility, conformability, and structural resilience.

Application-based segmentation highlights how clinical indication drives device selection and procedure planning. Intracranial aneurysm treatment remains a core use case, encompassing fusiform, saccular, and wide-neck presentations that demand discrete device attributes and deployment strategies. Peripheral aneurysm applications, present in both fusiform and wide-neck forms, introduce additional considerations related to vessel size, flow dynamics, and post-procedure surveillance pathways. These anatomical distinctions guide multidisciplinary decision-making and inform device labeling, training curricula, and post-market evidence collection.

End-user segmentation-spanning ambulatory surgical centers, hospitals, and specialty clinics-affects not only purchasing pathways but also procedural workflows and device design requirements. Ambulatory settings prioritize low-profile delivery systems and streamlined perioperative protocols that minimize resource utilization, whereas hospitals may favor devices supported by robust clinical data and warranty programs. Specialty clinics, often focused on targeted vascular niches, value devices that offer a favorable balance of cost and clinical performance.

Material-focused segmentation underscores how cobalt chromium, nitinol, and platinum each contribute to device behavior and clinical handling. Coatings comprise another critical dimension: bare metal finishes remain relevant where long-term endothelialization is prioritized, hydrophilic coatings reduce friction during navigation in tortuous anatomies, and polymer coatings are explored for their potential to modulate biological response. Lastly, distribution channel segmentation-direct sales, hospital pharmacy, online sales, and retail pharmacy-shapes commercial engagement models. Direct sales facilitate clinical training and bundled services, hospital pharmacy routes integrate devices into institutional procurement cycles, online sales expand access for smaller providers, and retail pharmacy channels can play niche roles in adjunctive product availability. Understanding how these segmentation layers interact provides actionable insight into product prioritization, regulatory pathways, and commercialization tactics.

Regional intelligence detailing how regulatory regimes, clinical networks, and manufacturing footprints across major global regions drive differentiated adoption and commercialization strategies

Regional dynamics exert a profound influence on regulatory timelines, clinical adoption rates, and supply chain architectures across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, regulatory pathways and established clinical networks often enable rapid uptake of iterative device improvements, while procurement structures differ sharply between large academic centers and community hospitals. This variation drives manufacturers to adopt flexible commercial models that combine direct engagement with institutional purchasing groups and targeted support for ambulatory settings.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific reimbursement regimes and infrastructure variability. In parts of this region, centralized registries and pan-national clinical collaborations facilitate comparative effectiveness research, which manufacturers leverage to validate device performance across diverse patient populations. Simultaneously, emerging markets within the region show growing interest in locally adaptable solutions that balance cost, durability, and logistical simplicity.

Asia-Pacific demonstrates a mix of rapid technology adoption in advanced urban centers and evolving capability in peripheral healthcare systems. Strong domestic manufacturing capabilities in certain countries support local production and export strategies, while regulatory agencies are increasingly aligning with international standards to expedite approvals. Across all regions, differences in reimbursement frameworks, hospital infrastructure, and clinician training pathways drive divergent uptake patterns, making regional segmentation crucial to tailoring clinical evidence generation, commercial deployment, and post-market surveillance efforts.

Insight into how leading device manufacturers are combining product innovation, partnerships, and post-market evidence strategies to strengthen market positions and clinical value propositions

Leading device manufacturers and ecosystem participants are pursuing multiple pathways to sustain competitive advantage and to address evolving clinical needs. Many firms prioritize iterative product improvements-refining delivery systems for lower profile access, enhancing radiopacity through material selection, and exploring surface modifications to influence thrombogenicity-while concurrently investing in clinical evidence generation to support broader labeling claims and payer engagement. Strategic collaborations with imaging providers and surgical systems vendors are becoming more common, aiming to integrate device deployment with enhanced intraoperative visualization and navigation capabilities.

Corporate development activity is also notable: alliances, licensing arrangements, and selective acquisitions enable companies to fill technology gaps or to accelerate entry into adjacent indications such as peripheral aneurysm treatment. Commercially, organizations are experimenting with hybrid distribution models that combine dedicated clinical support through direct salesforces with scalable online channels for standardized product lines. Post-market surveillance and registry participation are treated as strategic priorities to demonstrate long-term safety and durability, which in turn influence purchasing decisions among hospitals and specialty clinics.

Finally, firms are increasingly aware of the need to align product roadmaps with service offerings, including clinician training programs, reimbursement support, and outcome-monitoring solutions. These integrated approaches address buyer needs holistically and create higher switching costs for customers, while simultaneously generating richer real-world evidence that can be leveraged for regulatory and reimbursement discussions.

Actionable strategic recommendations for manufacturers, distributors, and clinical leaders to enhance product adoption, supply resilience, and evidence-driven reimbursement outcomes

Industry leaders should pursue a set of prioritized actions to convert insights into sustainable advantage. Manufacturers must continue to invest in device architectures that reduce procedural complexity, improve visualization, and minimize material intensity without compromising structural integrity. Parallel investments in robust clinical registries and targeted randomized studies will bolster payer conversations and support broader clinical adoption, particularly for anatomies where long-term outcomes are critical to value assessments.

Commercially, firms should diversify distribution approaches by tailoring direct sales engagements to high-volume centers while leveraging hospital pharmacy pathways and online channels to reach smaller facilities and specialty clinics. Strategic partnerships with imaging and navigation technology providers can create bundled solutions that de-risk adoption for clinicians and improve procedural efficiency. Supply chain resilience should be a continuous priority: nearshoring critical manufacturing steps and diversifying supplier bases for cobalt chromium, nitinol, and platinum will mitigate tariff and logistics exposures.

From a clinical adoption perspective, investing in structured training programs and proctorship models that emphasize patient selection, antiplatelet management, and complication mitigation will accelerate safe uptake. Finally, aligning evidence generation with reimbursement strategies-by demonstrating not just procedural success but downstream reductions in retreatment and complication rates-will facilitate sustainable access across hospitals, ambulatory surgical centers, and specialty clinics.

Transparent multi-method research methodology combining clinician interviews, regulatory review, device registry analysis, and supply chain intelligence to validate strategic findings

This research synthesis is grounded in a multi-method approach that integrates primary stakeholder engagement with rigorous secondary source analysis. Primary inputs include in-depth interviews with clinicians across neurointerventional and vascular specialties, procurement leaders in hospital and ambulatory settings, and senior commercial executives involved in device strategy. These conversations were structured to surface nuanced perspectives on device performance, clinical decision-making, and procurement dynamics.

Secondary research included systematic reviews of peer-reviewed clinical literature, regulatory filings, device safety communications, and procedural guidelines from professional societies. In addition, device registries and publicly available post-market datasets were analyzed to identify trends in utilization patterns and safety signals. Supply chain and materials intelligence was informed by reviews of manufacturing capabilities, trade flow data, and tariff policy disclosures, complemented by interviews with sourcing and operations professionals.

Analytical methods combined qualitative synthesis with triangulation across data streams to validate findings and mitigate bias. Expert panels were convened to test hypotheses and to prioritize the strategic implications of observed trends. Throughout, attention was paid to transparency in data provenance and to acknowledging limitations inherent in public reporting and self-reported clinical outcomes. This methodology ensures that conclusions are both evidence-based and reflective of the operational realities faced by stakeholders across the device ecosystem.

Concise conclusion summarizing how technological, clinical, and commercial forces converge to define future trajectories for flow diverter adoption and sustained value creation

In sum, the trajectory of flow diverter technology is characterized by converging advances in device design, materials science, and clinical evidence that together expand therapeutic possibilities for complex aneurysm morphologies. Simultaneously, external forces-including tariff dynamics, evolving reimbursement frameworks, and regional heterogeneity in regulatory and clinical infrastructure-shape how and where innovations translate into patient care. Stakeholders who integrate supply chain resilience, evidence generation, and tailored commercial approaches will be best positioned to capture lasting clinical and commercial value.

Looking forward, the most successful organizations will be those that view devices not as standalone products but as components of integrated solutions that address clinician workflow, payer requirements, and patient outcomes. Strengthening collaborative partnerships across imaging, clinical training, and post-market surveillance will be essential to sustaining adoption momentum. Ultimately, a disciplined focus on durable clinical benefit, operational excellence, and adaptive commercialization will determine which innovations achieve broad clinical integration and long-term impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flow Diverters Market, by Product Type

  • 8.1. Dual Layer
    • 8.1.1. Cobalt Chromium
    • 8.1.2. Nitinol
    • 8.1.3. Platinum
  • 8.2. Pipeline Flex
  • 8.3. Silk
  • 8.4. Single Layer
    • 8.4.1. Cobalt Chromium
    • 8.4.2. Nitinol
    • 8.4.3. Platinum

9. Flow Diverters Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Nitinol
  • 9.3. Platinum

10. Flow Diverters Market, by Coating

  • 10.1. Bare Metal
  • 10.2. Hydrophilic Coated
  • 10.3. Polymer Coated

11. Flow Diverters Market, by Application

  • 11.1. Intracranial Aneurysm
    • 11.1.1. Fusiform
    • 11.1.2. Saccular
    • 11.1.3. Wide Neck
  • 11.2. Peripheral Aneurysm
    • 11.2.1. Fusiform
    • 11.2.2. Wide Neck

12. Flow Diverters Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Hospital Pharmacy
  • 12.3. Online Sales
  • 12.4. Retail Pharmacy

13. Flow Diverters Market, by End User

  • 13.1. Ambulatory Surgical Center
  • 13.2. Hospital
  • 13.3. Specialty Clinic

14. Flow Diverters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Flow Diverters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Flow Diverters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Flow Diverters Market

18. China Flow Diverters Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Acandis GmbH
  • 19.7. Asahi Intecc
  • 19.8. BALT Extrusion SA
  • 19.9. Cook Medical LLC
  • 19.10. InspireMD, Inc.
  • 19.11. Johnson & Johnson
  • 19.12. Medtronic plc
  • 19.13. MicroPort Scientific Corporation
  • 19.14. Penumbra, Inc.
  • 19.15. phenox GmbH
  • 19.16. Rapid Medical Ltd.
  • 19.17. Stryker Corporation
  • 19.18. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLOW DIVERTERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLOW DIVERTERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLOW DIVERTERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. GCC FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 206. GCC FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 207. GCC FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. GCC FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 209. GCC FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 211. GCC FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 212. GCC FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 239. G7 FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 240. G7 FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. G7 FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 242. G7 FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 244. G7 FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 245. G7 FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. G7 FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. NATO FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 250. NATO FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 251. NATO FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. NATO FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 253. NATO FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 255. NATO FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 256. NATO FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. NATO FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)